Orange Book product · Brand (NDA)
VOSTALLY
RAMIPRIL
At a glance
Jul 23, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 23, 2025
11 mo ago
Today
Patent 12343338 expires
Listed drug product patent expiration.
Aug 16, 2039
in 13 yr 4 mo
Pharmaceutical detail
Active ingredient
RAMIPRIL
Strength
1MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 219757
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2007ALTACEBrand (NDA)
NDA 022021 · KING PFIZER
- 1991ALTACEBrand (NDA)
NDA 019901 · KING PHARMS LLC
- 2015RAMIPRILGeneric (ANDA)
ANDA 091069 · APOTEX
- 2014RAMIPRILGeneric (ANDA)
ANDA 202392 · ACCORD HLTHCARE
- 2011RAMIPRILGeneric (ANDA)
ANDA 090650 · NATCO PHARMA
- 2011RAMIPRILGeneric (ANDA)
ANDA 091604 · AUROBINDO PHARMA LTD
- 2009RAMIPRILGeneric (ANDA)
ANDA 090697 · ZYDUS PHARMS USA INC
- 2009RAMIPRILGeneric (ANDA)
ANDA 078849 · RANBAXY LABS LTD
- 2008RAMIPRILGeneric (ANDA)
ANDA 078832 · ZYDUS PHARMS USA
- 2008RAMIPRILGeneric (ANDA)
ANDA 077004 · CIPLA
- 2008RAMIPRILGeneric (ANDA)
ANDA 079116 · COREPHARMA
- 2008RAMIPRILGeneric (ANDA)
ANDA 077513 · ACTAVIS ELIZABETH
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12343338 | Aug 16, 2039 | in 13 yr 4 mo | ProductU-4233 |

